In this Issue
The Forces Driving Care
Guest Chief Medical Editors’ Page
By Gary M. Ansel, MD, FACC; and Koen Deloose, MD
A formal credentialing criteria for femoropopliteal chronic total occlusions.
By John A. Phillips, MD
The current treatment landscape for complex superficial femoral artery lesions and recommendations for improvement.
By Luis Mariano Palena, MD; Efrem Gomez Jabalera, MD; and Marco Manzi, MD
Michael R. Jaff, DO, answers questions posed by Gary M. Ansel, MD, FACC, and Koen Deloose, MD, on the challenges of his new role as hospital president and how new regulatory and reimbursement models might affect vascular care delivery.
With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; and Koen Deloose, MD
By Tony S. Das, MD, FACP, FACC; and Yann Gouëffic, MD, PhD
Defining the terms, discussing the data, and reviewing perspectives on current practices.
By Ehrin J. Armstrong, MD; and Marianne Brodmann, MD
Dr. Rocha-Singh discusses the available methods for calcium assessment and scoring, how calcium affects procedural success, and the goals of the VIVA calcium scoring unification initiative.
With Krishna Rocha-Singh, MD
Juan Granada, MD, discusses potential next-generation advancements in drugs, delivery methods, and study.
With Juan F. Granada, MD, FACC
Ask the Experts: Perfect Pairing: Which Stent Properties Are the Best Match for Drug-Coated Balloons?
Experts weigh in on properties of available stent technology and which combinations could be used to improve femoropopliteal disease outcomes.
With Stavros Spiliopoulos, MD, PhD, EBIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Mark W. Burket, MD; and Thomas Zeller, MD
FEATURED TECHNOLOGYSponsored by PQ Bypass
With long-term durability of SFA interventions still a challenge, a new approach should be considered.
By Grzegorz Halena, MD, PhD; and Jane Bailly, PhD
MEDICAL AFFAIRS CORNERSponsored by Medtronic
By Venkatesh G. Ramaiah, MD, FACS
FEATURED STUDYSponsored by Cardiovascular Systems, Inc.
A roundtable discussion of the real-world LIBERTY 360° 12-month data and the study’s significance in treating patients with peripheral artery disease and critical limb ischemia.
With Ehrin J. Armstrong, MD; Jihad A. Mustapha, MD; George A. Pliagas, MD; and Jason A. Yoho, MD
EUROPEAN FEATURED TECHNOLOGYSponsored by Veryan Medical Ltd.
Producing better results in primary stenting and the ideal complement to drug-coated balloons.
By Peter A. Gaines, MD
SOCIETY UPDATE: ACTiVE
Dr. Kush Desai discusses the genesis of the ACTiVE educational forum, VTE intervention, and IVC filter retrieval.
With Kush Desai, MD
Prof. Powell discusses her work as a trial investigator, including what the latest EVAR data show and areas that warrant further study.